Can TRT Be Safe With a PFO and Tachycardia? (TRT Q&As)
Timeline
Dr. O’Connor discusses the potential for a PFO to allow a venous clot to cross into the arterial circulation and emphasizes minimizing factors that increase clotting risk. He recommends a cautious approach to testosterone, cardiovascular evaluation, and close attention to red blood cells and other risk factors.
A 20-year-old man reports being hospitalized in the ICU for two weeks with liver bleeding and AST and ALT levels in the thousands. Dr. O’Connor considers the event extremely serious, discusses steroid-related liver injury and the possibility of additional oral steroid exposure, and strongly cautions against returning to anabolic steroids.
A 40-year-old man with longstanding low testosterone and significant obesity describes changing testosterone doses and struggling with elevated estrogen. Dr. O’Connor emphasizes weight loss, smaller and more frequent testosterone dosing, sparing use of aromatase inhibitors, and monitoring the ABCDs™, including glucose, blood pressure, cardiovascular risk, and red blood cell-related markers.
Video Summary
This mailbag discussion focuses on questions about laboratory concerns that arise during testosterone therapy. It explains why certain lab changes are expected and how monitoring helps differentiate adaptation from risk. Lab review is framed as a safety process rather than a trigger for immediate intervention.
A central portion discusses how markers such as hematocrit and hormone levels should be interpreted together over time. The episode emphasizes recognizing trends and context before making changes. Proportional interpretation is highlighted to avoid unnecessary disruption.
The closing segment reinforces laboratory monitoring as a core component of long-term testosterone management. Ongoing follow-up, documentation, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from steady oversight rather than reactive adjustment.
Drug Callouts
Condition Callouts
Key Takeaways
- Some lab changes are expected during therapy.
- Trend-based interpretation improves safety.
- Proportional responses prevent overreaction.
- Monitoring supports stable long-term treatment.
- Contextual review guides better decisions.